JP2003516815A - 自己血小板ゲルとその膜を調製する方法、およびこの方法を実施するためのキット - Google Patents

自己血小板ゲルとその膜を調製する方法、およびこの方法を実施するためのキット

Info

Publication number
JP2003516815A
JP2003516815A JP2001544923A JP2001544923A JP2003516815A JP 2003516815 A JP2003516815 A JP 2003516815A JP 2001544923 A JP2001544923 A JP 2001544923A JP 2001544923 A JP2001544923 A JP 2001544923A JP 2003516815 A JP2003516815 A JP 2003516815A
Authority
JP
Japan
Prior art keywords
platelet
membrane
capsule
batroxobin
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001544923A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003516815A5 (https=
Inventor
サッチ・マリア・クリスチーナ
ベッランダ・マルコ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2003516815A publication Critical patent/JP2003516815A/ja
Publication of JP2003516815A5 publication Critical patent/JP2003516815A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005—Ingredients of undetermined constitution or reaction products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Surgical Instruments (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP2001544923A 1999-12-14 2000-12-13 自己血小板ゲルとその膜を調製する方法、およびこの方法を実施するためのキット Pending JP2003516815A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT99U000010 1999-12-14
IT1999AL000010U ITAL990010U1 (it) 1999-12-14 1999-12-14 Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico.
PCT/EP2000/012661 WO2001043787A2 (en) 1999-12-14 2000-12-13 A process for preparing an autologous platelet gel and membrane thereof

Publications (2)

Publication Number Publication Date
JP2003516815A true JP2003516815A (ja) 2003-05-20
JP2003516815A5 JP2003516815A5 (https=) 2011-09-01

Family

ID=11333478

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544923A Pending JP2003516815A (ja) 1999-12-14 2000-12-13 自己血小板ゲルとその膜を調製する方法、およびこの方法を実施するためのキット

Country Status (12)

Country Link
US (1) US6841170B2 (https=)
EP (1) EP1239895B1 (https=)
JP (1) JP2003516815A (https=)
AT (1) ATE237370T1 (https=)
AU (1) AU2511101A (https=)
CA (1) CA2393315C (https=)
DE (1) DE60002231T2 (https=)
DK (1) DK1239895T3 (https=)
ES (1) ES2197125T3 (https=)
IT (1) ITAL990010U1 (https=)
PT (1) PT1239895E (https=)
WO (1) WO2001043787A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007508530A (ja) * 2003-10-10 2007-04-05 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ 流動性生体物質の遠心分離および処理のための使い捨て型容器

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2458753A1 (en) * 2001-08-27 2003-03-06 The Cleveland Clinic Foundation Compositions, methods and apparatus for surgical procedures
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
DE10392686T5 (de) 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
ITMI20021917A1 (it) * 2002-09-10 2004-03-11 New Dawn Consultores E Servicos L Da Attivatore per la formazione di gel piastrinico, gel di plasma povero di piastrine o gel di plasma ricco di piastrine.
US20060095121A1 (en) * 2004-10-28 2006-05-04 Medtronic Vascular, Inc. Autologous platelet gel on a stent graft
PL1848473T3 (pl) * 2005-02-07 2013-11-29 Hanuman Llc Urządzenie - koncentrator osocza
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
ES2324438B1 (es) * 2006-06-19 2010-05-25 Lorente Alvarez-Beigbeder, S.L. Metodo para la obtencion de plaquetas.
US20080255041A1 (en) * 2007-04-11 2008-10-16 Ebi, L.P. Treatment of annulus fibrosis defects
WO2008127639A1 (en) 2007-04-12 2008-10-23 Biomet Biologics, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
WO2009111338A1 (en) * 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
ITFI20080070A1 (it) * 2008-04-04 2009-10-05 Azienda Ospedaliero Universitaria Careggi Matrice extracellulare comprendente fattori piastrinici.
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
EP2470229B1 (en) 2009-06-11 2017-08-23 Universitat Autònoma De Barcelona Use of gelled prp (platelet gel) for volumetric breast reconstruction
IT1394570B1 (it) 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9555171B2 (en) 2010-09-30 2017-01-31 Depuy Mitek, Llc Methods and devices for collecting separate components of whole blood
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US20170369845A1 (en) * 2014-12-31 2017-12-28 Anthrogenesis Corporation Methods for isolation of platelets
IT201700024672A1 (it) * 2017-03-06 2018-09-06 Caloprisco Gaetano Ditta Individuale Metodo e sistema per preparare un kit medicale per curare lesioni tissutali di un paziente
US11767511B2 (en) 2018-11-30 2023-09-26 Cellphire, Inc. Platelets as delivery agents
EP3887404A4 (en) 2018-11-30 2022-11-02 Cellphire, Inc. SLIDES LOADED WITH ANTI-CANCER AGENTS
AU2020267368B2 (en) 2019-05-03 2023-05-04 Cellphire, Inc. Materials and methods for producing blood products
EP4013496A4 (en) 2019-08-16 2023-10-18 Cellphire Inc. THROMBOSOMES AS AN AGENT FOR REMOVING THE THROMBOCYTE AGGREGATION-INHIBITING EFFECT
CA3170201A1 (en) 2020-02-04 2021-08-12 Cellphire, Inc. Methods of treating congenital hemophilia with anti-fibrinolytic loaded platelets
TW202245814A (zh) 2021-02-17 2022-12-01 美商賽菲爾公司 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物
CN114831770A (zh) * 2022-05-20 2022-08-02 上海浦灵生物科技有限公司 一种肺动脉高压非人灵长类动物模型及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
IT1284550B1 (it) 1996-09-18 1998-05-21 Flavio Tarantino Procedimento per la preparazione di colla di fibrina autologa ad uso chirurgico

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007508530A (ja) * 2003-10-10 2007-04-05 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ 流動性生体物質の遠心分離および処理のための使い捨て型容器

Also Published As

Publication number Publication date
ITAL990010U1 (it) 2001-06-14
EP1239895B1 (en) 2003-04-16
DE60002231T2 (de) 2004-04-29
PT1239895E (pt) 2003-08-29
EP1239895A2 (en) 2002-09-18
ATE237370T1 (de) 2003-05-15
US6841170B2 (en) 2005-01-11
CA2393315A1 (en) 2001-06-21
ES2197125T3 (es) 2004-01-01
CA2393315C (en) 2010-01-26
US20020172666A1 (en) 2002-11-21
DK1239895T3 (da) 2003-07-21
WO2001043787A3 (en) 2001-12-13
AU2511101A (en) 2001-06-25
WO2001043787B1 (en) 2002-01-10
DE60002231D1 (de) 2003-05-22
WO2001043787A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
JP2003516815A (ja) 自己血小板ゲルとその膜を調製する方法、およびこの方法を実施するためのキット
US6368298B1 (en) Preparing autologous fibrin glue
EP1066838B1 (en) Bone tissue regenerating composition
RS56189B1 (sr) Postupci, cev i uređaj za dobijanje kompozicije za zarastanje rana
US20120213755A1 (en) Semi-synthetic platelet gel and method for the preparation thereof
EP2164541A2 (en) Fluid concentrator, autologous concentrated body fluids, and uses thereof
CA1248435A (en) Process and device for the detection of pathogens
JP2012006937A (ja) 液体成分を分離する方法及び装置
CN113244458A (zh) 一种用于修复关节软骨损伤的复合材料及其制备方法
KR101522888B1 (ko) 자기혈청 첨가 골수세포 배양 시스템, 자기혈청 첨가 골수세포 배양방법 및 자기혈청 첨가 배양 골수세포를 유효성분으로 하는 의약조성물의 제조방법
TWI411443B (zh) 富含血小板血漿衍生之生長因子複合物之製備方法以及於活體外促進一組織生長之方法
JP6999927B2 (ja) 多血小板血漿を製造する方法
JPH06510035A (ja) 細胞を収容する生物学的適合性カプセルを製造する方法
ES2464819T3 (es) Matriz extracelular que comprende factores plaquetarios
CN1247271C (zh) 生产血纤蛋白胶等血制品的装置及医学用途
Mansour et al. Use of concentrated growth factor (CGF) in implantology
US8124130B1 (en) Formulations and methods for recovery from dental surgery
EP1155706A1 (en) Apparatus for production of fibrin glue and its medical application
RU2833471C1 (ru) Модульный комплект для экстракорпоральной фармакотерапии (варианты)
RU2543324C2 (ru) Способ получения медицинского геля, применяемого для сепарации эритроцитов и лейкоцитов методом центрифугирования
JP6959031B2 (ja) 多血小板血漿をゲル化させるゲル化方法、及びゲル化方法に用いられるキット
US20140107699A1 (en) Active loaded fixation devices
RU2067866C1 (ru) Способ получения ингибитора клеточной пролиферации
RU2683322C1 (ru) Способ пролонгирования высвобождения биологически активных веществ из теней эритроцитов
RU2290939C2 (ru) Средство для лечения повреждений спинного и головного мозга

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110218

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7421

Effective date: 20110303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110518

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110525

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110620

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110627

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20110715

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110816

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20110824